INVEST | SKY

Search Result

BGNE | BeiGene Ltd 百济神州

You can also get more BGNE info from:

MarketWatch CNBC SeekingAlpha Y!Finance BarChart Zacks TheStreet QuoteMedia FinViz Benzinga StockTwits Ycharts GuruFocus StockAnalysis MarketBeat 美股之家 StreetInsider 雪球 Tiingo Stocks Trading Charts WSJ TradingView Martkets Insider Robinhood OTC Markets Chartmill Barrons MarketChameleon Stocklight StockMarketWatch Stockhouse TD Ameritrade TalkMarkets Stocknews Tipranks InvestorsObserver RealMoney StockConsultant Stockinvest Investorplace Swingtradebot WalletInvestor DividendInvestor Dogsofthedow Echofin TradingEconomics Polygon Equities Fidelity StockInvestor Fintel EarningsWhispers StockMonitor InvestingPort Whotrades CapitalMarketLaboratories FinancialContent TMX Money Stocks2 Trade-ideas InsiderTracking Kiplinger CNN SEC Fillings WhaleWisdom iBorrowDesk 雪球 Webb-Site MG21 MG21 Y!Finance Chart WhaleWisdom MacroAxis OutstandingSharesRecord HoldingsChannel StratoSphere

EXPAND

MyTrack

Result:1

Revenue Track

Quarterly Annual

Stock price graph

1M 3M 1y 5Y All

Rank

Default▼ Market Value Year Founded IPO A-Z CRG Score

BGNE | BeiGene Ltd

Manufacturing | Pharmaceutical Preparation Manufacturing
Market Value: $13.97 Billion
Shares: 103,631,826
52-Week Range: 118-392
PS Ratio Estimate: 30.8 (based on most recent quarter revenue x 4)

BGNE www.beigene.com HQ: Beijing, China

IPO: 2016-02-03 Year Founded: 2010

Search Founders: Xiao Dong Wang John V. Oyler

Core Business: BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290).

QTsky is a question & task based crowdsourcing research platform - you can post any research need - whether it's a simple question or a complex task - and find the right industry expert or software engineer to help you obtain the right answer or solution. And you only pay on a per-question or per-task basis after your QT is completed

QTsky.com and all of its information providers will not be liable for any errors,omissions,delays or interruptions in all the information and data on the QTsky.com website or for any damages relating to your use of the information provided herein. All data,research findings,opinions and information herein, whether provided by QTsky.com or by its users,should not be treated as professional investment advice.